Aerovate Therapeutics Inc... (AVTE)
NASDAQ: AVTE
· Real-Time Price · USD
2.68
0.00 (0.00%)
At close: Apr 28, 2025, 3:59 PM
Aerovate Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 136K | 136K | 136K | 136K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 84K | 112K | 84K | 109K | 103K | 96K | 88K | 83K | 78K | 68K | 56K | 39K | 22K | 13K | 5K | 2K | 2K |
Gross Profit | -28K | -56K | -84K | -109K | -103K | -96K | -88K | -83K | -78K | -68K | -56K | -39K | -24K | -15K | -7K | -4K | -2K |
Operating Income | -53.37M | -74.6M | -90.26M | -94.22M | -88.39M | -81.41M | -75.19M | -67.98M | -59.86M | -53.24M | -45.65M | -37.7M | -31.26M | -23.02M | -18.42M | -14.46M | -10.31M |
Interest Income | 4.48M | 5.04M | 5.72M | 6.34M | 6.26M | 5.95M | 5.17M | 3.92M | 2.84M | 1.83M | 899K | 355K | 127K | 18K | 18K | 2K | n/a |
Pretax Income | -48.91M | -69.57M | -84.56M | -87.88M | -82.13M | -75.47M | -70.11M | -64.13M | -57.1M | -51.49M | -44.71M | -37.3M | -31.09M | -22.96M | -18.41M | -14.53M | -10.96M |
Net Income | -48.96M | -69.63M | -84.61M | -87.94M | -82.19M | -74.4M | -69.01M | -62.47M | -55.21M | -50.61M | -43.81M | -36.98M | -30.98M | -22.96M | -18.41M | -14.53M | -10.96M |
Selling & General & Admin | 20.26M | 21.38M | 20.73M | 18.14M | 17.52M | 17.16M | 16.57M | 15.45M | 15M | 14.62M | 14.21M | 13.62M | 11.21M | 8.04M | 5.18M | 2.67M | 1.38M |
Research & Development | 33.11M | 53.19M | 69.47M | 76.03M | 70.81M | 64.22M | 58.63M | 52.53M | 44.85M | 38.62M | 31.45M | 24.08M | 20.05M | 14.99M | 13.24M | 11.79M | 8.93M |
Other Expenses | 3K | n/a | -2K | -1K | -2K | n/a | -78K | -75K | -80K | -79K | -1K | -5K | -2K | -3K | -7K | -7K | -4K |
Operating Expenses | 53.37M | 74.57M | 90.2M | 94.16M | 88.33M | 81.38M | 75.19M | 67.98M | 59.86M | 53.24M | 45.65M | 37.7M | 31.26M | 23.02M | 18.42M | 14.46M | 10.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65K | 65K | 65K | 65K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -28K | -56K | -56K | -56K | -28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 49.98M | 74.6M | 90.26M | 94.22M | 88.39M | 81.41M | 75.19M | 67.98M | 59.86M | 53.24M | 45.65M | 37.7M | 31.26M | 23.02M | 18.42M | 14.46M | 10.31M |
Income Tax Expense | 55K | 39.72K | 40.72K | 15.72K | 15.72K | -1.09M | -1.12M | -1.66M | -1.88M | -763K | -785K | -221K | 1K | n/a | -3K | -3K | -1K |
Shares Outstanding (Basic) | 28.98M | 28.61M | 28.86M | 28.76M | 27.8M | 27.7M | 27.64M | 25.17M | 24.78M | 24.61M | 24.45M | 24.41M | 24.41M | 24.41M | 23.89M | 243.08K | 21.58M |
Shares Outstanding (Diluted) | 28.98M | 28.61M | 28.86M | 28.76M | 27.8M | 27.7M | 27.64M | 25.17M | 24.78M | 24.61M | 24.45M | 24.41M | 24.41M | 24.41M | 23.89M | 243.08K | 21.58M |
EPS (Basic) | -1.7 | -2.44 | -2.99 | -3.14 | -3.04 | -2.83 | -2.7 | -2.55 | -2.28 | -2.11 | -1.84 | -1.54 | -24.85 | -24.53 | -39.27 | -49.13 | -34.39 |
EPS (Diluted) | -1.7 | -2.44 | -2.99 | -3.14 | -3.04 | -2.83 | -2.7 | -2.55 | -2.28 | -2.11 | -1.84 | -1.54 | -24.85 | -24.53 | -39.27 | -49.13 | -34.39 |
EBITDA | -53.11M | -74.31M | -89.96M | -94.11M | -88.28M | -81.31M | -75.11M | -67.9M | -59.78M | -53.17M | -45.6M | -37.66M | -31.24M | -23.01M | -19.06M | -15.1M | -10.96M |
EBIT | -49.98M | -74.6M | -90.26M | -94.22M | -88.39M | -81.41M | -75.19M | -67.98M | -59.86M | -53.24M | -45.65M | -37.7M | -31.26M | -23.02M | -19.06M | -15.11M | -10.96M |
Depreciation & Amortization | 254K | 282K | 302K | 109K | 103K | 96K | 88K | 83K | 78K | 68K | 56K | 39K | 24K | 15K | 8K | 2.25M | 2.25M |